Burning Rock Biotech Files 6-K, Incorporates into F-3/S-8

Ticker: BNR · Form: 6-K · Filed: Sep 20, 2024 · CIK: 1792267

Sentiment: neutral

Topics: sec-filing, 6-k, registration-statement

Related Tickers: BNR

TL;DR

Burning Rock Biotech (BNR) filed a 6-K on 9/20, incorporating into F-3/S-8. Standard update.

AI Summary

Burning Rock Biotech Ltd. filed a Form 6-K on September 20, 2024, to report information for the month of September 2024. The filing is incorporated by reference into their existing registration statements on Form F-3 (File No. 333-264577) and Form S-8 (File No. 333-251191). The company is based in Guangzhou, People's Republic of China.

Why It Matters

This filing serves to update or supplement information related to Burning Rock Biotech's existing SEC registration statements, potentially impacting investors' understanding of the company's ongoing compliance and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report and does not appear to contain new material financial or operational information that would significantly alter the company's risk profile.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K is to report information for the month of September 2024 and to be incorporated by reference into the company's existing registration statements on Form F-3 (File No. 333-264577) and Form S-8 (File No. 333-251191).

When was this Form 6-K filed?

This Form 6-K was filed on September 20, 2024.

What are the company's principal executive offices?

The company's principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.

Which registration statements does this filing get incorporated into?

This filing is incorporated by reference into the company's registration statements on Form F-3 (File No. 333-264577) and Form S-8 (File No. 333-251191).

Does Burning Rock Biotech file annual reports under Form 20-F or 40-F?

Burning Rock Biotech indicates that it files annual reports under Form 20-F.

Filing Stats: 300 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-09-20 07:27:54

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Burning Rock Biotech Limited By: /s/ Yusheng Han Name: Yusheng Han Title: Chief Executive Officer Date: September 20, 2024 4

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing